Skip to main content
. 2020 Nov 17;8(4):489. doi: 10.3390/healthcare8040489

Table 4.

Outcome scores for each group at baseline (week 0), post-intervention (week 4), follow-up (week 8), and follow-up 2 (week 12): mean and standard deviation.

Outcome Measure Hip Group Quadriceps Group Control F p Post Hoc
Mean (SD) Mean (SD) Mean (SD)
Flexion ROM
Baseline 114.42 ± 10.52 115.15 ± 9.33 117 ± 5.79 0.378 0.687
4 week f/w 118.32 ± 9.39 120.4 ± 7.25 118.44 ± 5.66 5.8 0.005 * B > C
8 week f/w 119.53 ± 9.19 121.45 ± 6.73 118.56 ± 5.64 9.274 0.001 * A, B > C
12 week f/w 119.84 ± 8.82 122.7 ± 6.4 118.88 ± 5.62 11.006 0.001 * A, B > C
Time × Group 3.382 0.004 *
Extension ROM
Baseline 10.37 ± 5.6 8.1 ± 3.58 9.13 ± 3.09 1.371 0.263
4 week f/w 8.58 ± 4.76 6.8 ± 2.72 8.19 ± 2.56 1.509 0.231
8 week f/w 7.79 ± 4.41 6.2 ± 2.3 8 ± 2.65 4.776 0.013 * A, B > C
12 week f/w 7.84 ± 4.11 6.1 ± 2.33 7.63 ± 2.6 2.604 0.084
Time × Group 2.291 0.041 *
WOMAC-P
Baseline 12.32 ± 2.42 12.75 ± 2.78 12.19 ± 2.56 0.239 0.788
4 week f/w 8.21 ± 4.14 10.1 ± 2.97 11.25 ± 1.91 6.547 0.003 * A > C
8 week f/w 8.37 ± 2.56 9.6 ± 2.41 11 ± 2.12 11.474 0.001 * A, B > C
12 week f/w 8.05 ± 3.2 9.8 ± 2.39 10.69 ± 2.15 7.677 0.001 * A > C
Time × Group 3.493 0.004 *
WOMAC-F
Baseline 41.89 ± 5.36 45.1 ± 7.13 45.31 ± 4.78 1.931 0.155
4 week f/w 33.74 ± 8.93 38.2 ± 6.38 43.56 ± 3.75 8.464 0.001 * A, B > C
8 week f/w 33.32 ± 8.49 37.35 ± 5.94 41.5 ± 4.32 5.767 0.006 * A > C
12 week f/w 32.05 ± 8.76 36.75 ± 5.32 40.31 ± 4.84 5.499 0.007 * A > C
Time × Group 1.456 0.201

SD, standard deviation; ROM, range of motion; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index. * p < 0.05.